Elisabeth Roider is Harvard-and Swiss-trained, internationally renowned physician scientist. As a Partner & Chief Scientific and Medical Officer at Maximon is she dedicated to bring the field of longevity to the next level. As a physician-scientist, she works at the University Hospital of Basel and the Harvard Medical School. Her multidisciplinary team includes clinicians and clinical trial specialists, biologists, chemists, machine learning specialists, mathematicians, statisticians, and epidemiologists, allowing a bench-to-bedside approach to solve complex, medical questions in the most efficient way. Her work has resulted in various high-impact publications, patents and awards. Driven by the mission to identify and solve the most relevant medical and public health problems, Elisabeth most recently joined Maximon as a Partner Chief Scientific and Medical Officer. Here she aims to support scientists and physicians in transforming true innovation into solid solutions and products, helping patients and consumers to achieve a better, healthier and finally longer life.

Chapters

00:00 Introduction to Longevity and the Guest's Background

02:49 The Intersection of Medicine, Science, and Business in Longevity

05:57 Innovative Senior Living Concepts and Mental Health

08:48 The Evolving Longevity Industry and Its Mainstream Acceptance

11:55 Economic Implications of Longevity and Preventative Medicine

14:50 Challenges in Healthcare Systems and Chronic Disease Management

17:59 The Role of GLP-1 Agonists and Other Treatments in Longevity

20:48 Practical Longevity Strategies and Personal Health Optimization

24:00 Testing and Monitoring for Longevity

26:56 Conclusion and Future Directions in Longevity Research

$530,000 Of Taylor Swift Debt | Financial Audit

Financial Audit

Who Should Cover Christmas and Kid Expenses?

The AI-powered Podcast Player